According to TechSci Research report, “Single-Use Pump Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Single-Use Pump Market was valued at USD 1.27 Billion in 2024 and is expected to reach USD 2.67 Billion by 2030 with a CAGR of 12.99%. The Single-Use Pump Market is experiencing significant growth, driven primarily by the increasing adoption of single-use technologies (SUTs) in the biopharmaceutical and life sciences industries, where they are revolutionizing the manufacturing of biologics, vaccines, and cell and gene therapies. Single-use pumps offer enhanced operational flexibility, reduced contamination risk, and faster turnaround times, which are critical in the production of high-value, sensitive biological products.

As pharmaceutical companies continue to shift from traditional stainless-steel systems to disposable platforms, the demand for pumps that can seamlessly integrate into these modular systems has surged. Additionally, the growing focus on personalized medicine and the rise of small-batch production requires pumps that can operate reliably at varying volumes without extensive cleaning or validation, making single-use pumps an attractive solution. Another key factor driving market expansion is the biological market boom, fueled by the increasing prevalence of chronic diseases, rising investments in research and development, and the ongoing need for innovative therapeutics.

The scalability of single-use systems also allows manufacturers to expand production capacity quickly and cost-effectively, addressing both commercial and clinical production demands. Moreover, the implementation of strict regulatory standards regarding contamination control and process validation has prompted manufacturers to adopt single-use pumps, which minimize cross-contamination risks and simplify compliance processes. Technological advancements have further strengthened market growth, as modern single-use pumps now offer improved precision, energy efficiency, and compatibility with a wide range of bioprocess fluids, including shear-sensitive and viscous media.

The increasing collaboration between pump manufacturers and pharmaceutical companies to co-develop specialized solutions tailored for specific processes also supports market momentum. Beyond biopharma, rising applications in food and beverage, chemical, and cosmetics industries are contributing to demand, as these sectors seek hygienic, low-maintenance pumping solutions capable of handling diverse fluid types. Cost-effectiveness, combined with the reduced need for cleaning, sterilization, and downtime, further positions single-use pumps as an attractive alternative to conventional pumping systems.

Download Free Sample Report
https://www.techsciresearch.com/sample-report.aspx?cid=30513

Customers can also request 10% free customization in this report.

Based on the Sterilization, Gamma Irradiation segment held the largest Market share in 2024. The Gamma Irradiation segment is a key driver for the global Single-Use Pump Market, primarily due to its critical role in ensuring sterility and safety in biopharmaceutical, medical, and life sciences applications. Gamma irradiation provides an effective and reliable method of sterilizing single-use systems, including pumps, tubing, and connectors, without compromising their integrity or functionality, which is essential for maintaining aseptic conditions during production processes.

As regulatory authorities worldwide continue to enforce stringent guidelines for contamination control in the manufacture of biologics, vaccines, and other sensitive therapeutics, the demand for gamma-irradiated single-use pumps has grown significantly. These pumps allow manufacturers to reduce the risk of cross-contamination, streamline production processes, and achieve faster batch turnaround times, supporting the increasing emphasis on efficiency and safety in drug development and production. Moreover, the flexibility and disposability of gamma-irradiated single-use pumps reduce the need for complex cleaning and sterilization procedures, thereby lowering operational costs and minimizing downtime, which is particularly attractive to contract manufacturing organizations and large-scale biopharmaceutical producers.

The ongoing expansion of the biopharmaceutical sector, fueled by rising demand for biologics, cell and gene therapies, and personalized medicine, further amplifies the adoption of gamma-irradiated single-use pump systems, as these technologies are critical to supporting scalable and contamination-free production. In addition, advancements in gamma irradiation technology have enhanced the reliability, uniformity, and throughput of sterilization processes, enabling manufacturers to meet high-volume production needs without compromising quality. The trend toward modular and flexible manufacturing facilities, combined with growing investment in contract manufacturing and outsourced bioproduction, has positioned gamma-irradiated single-use pumps as an essential component for modern pharmaceutical operations.

Furthermore, the global push toward rapid vaccine production, accelerated by public health crises and pandemic preparedness, has highlighted the importance of pre-sterilized, ready-to-use single-use systems, including pumps, to ensure safe and efficient bioprocessing. The ability to maintain sterile fluid handling while supporting complex processes such as filling, mixing, and transfer makes gamma-irradiated pumps a preferred choice across diverse applications, from upstream cell culture to downstream purification. Collectively, these factors—including regulatory compliance, operational efficiency, cost-effectiveness, scalability, and safety—underscore the growing reliance on gamma-irradiated single-use pumps, positioning this segment as a prominent driver of market growth, innovation, and adoption across global biopharmaceutical and life sciences industries.

Based on region, The Asia-Pacific region is emerging as the fastest-growing market for single-use pumps, driven by the rapid expansion of the biopharmaceutical and life sciences industries. Rising production of biologics, vaccines, and cell & gene therapies, coupled with increasing investments in bioprocessing facilities and contract manufacturing organizations (CMOs), is fueling demand for scalable and contamination-free fluid handling solutions. Additionally, governments across the region are supporting healthcare infrastructure development and advanced manufacturing technologies, further accelerating adoption. Growing awareness of continuous manufacturing and single-use technologies among local manufacturers positions Asia-Pacific as a key growth engine in the global single-use pump market.

Major companies operating in the Global Single-Use Pump Market are:

GE Healthcare Life Sciences
Sartorius AG
Thermo Fisher Scientific Inc.
Pall Corporation (Danaher company)
Watson-Marlow Fluid Technology Group (WMFTG)
Eppendorf AG
Cole-Parmer Instrument Company LLC
Iveka, Inc.
Admix Inc.
Asahi Kasei Corporation

Download Free Sample Report
https://www.techsciresearch.com/sample-report.aspx?cid=30513

Customers can also request 10% free customization in this report.

“The Global Single-Use Pump Market is expected to rise in the upcoming years and register a significant CAGR during the forecast period. The Single-Use Pump Market is poised for robust growth, driven by the expanding biopharmaceutical and life sciences sectors, where efficient, contamination-free fluid handling is critical. Rising global demand for biologics, vaccines, and cell & gene therapies is accelerating the adoption of single-use technologies. Concurrently, increased investments in bioprocessing facilities and contract manufacturing organizations (CMOs) are creating avenues for scalable and cost-efficient pump solutions.

The ongoing shift toward continuous manufacturing and process intensification further bolsters market potential. High-growth regions, notably Asia-Pacific and Latin America, present significant opportunities due to expanding healthcare infrastructure and rising biologics production, positioning single-use pumps as strategic enablers in modern biomanufacturing. Therefore, the Market of Single-Use Pump is expected to boost in the upcoming years.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based global management consulting firm.

“Single-Use Pump Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented, By Material (Polypropylene, Polyethylene, Polystyrene, Polycarbonate), By Application (Liquid Analysis, Environmental Monitoring, Medical Diagnostics, Pharmaceutical Production), By Sterilization (Gamma Irradiation, Ethylene Oxide, Steam), By Region, By Competition, 2020-2030F”, has evaluated the future growth potential of Global Single-Use Pump Market and provides statistics & information on the Market size, structure, and future Market growth. The report intends to provide cutting-edge Market intelligence and help decision-makers make sound investment decisions., The report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the Global Single-Use Pump Market.

Contact

Techsci Research LLC

420 Lexington Avenue,

Suite 300, New York,

United States- 10170

Tel: +13322586602

Email: [email protected]

Website: www.techsciresearch.com